Anthera Pharma (ANTH) Files $100M Mixed Shelf
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bill Barrett Corporation (BBG) Entered Confidentiality Agreement with Bonanza Creek Energy (BCEI) Pertaining to BCEI's Chapter 11 Proceeding
- Forward Pharma (FWP) Confirms Settlement and License Agreement with Biogen (BIIB)
- Two Harbors Investment (TWO) Prices $250M Convertible Senior Notes Offering
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!